Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present MiMedx Group, Inc. (NASDAQ: MDXG).

Full DD Report for MDXG

You must become a subscriber to view this report.


Recent News from (NASDAQ: MDXG)

MasTec +5.2% on move to MidCap 400; FTK -4.1% on exiting SmallCap 600
MasTec (NYSE: MTZ ) is up 5.2% after hours following news that it's heading into the S&P MidCap 400 , replacing United Natural Foods (NASDAQ: UNFI ). More news on: MasTec, Inc., United Natural Foods, Inc., MiMedx Group Inc., Stocks on the move, Energy stocks news, Healthcare stocks ...
Source: SeekingAlpha
Date: November, 07 2018 18:13
Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600
NEW YORK , Nov. 7, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent Jack Henry & Associates Inc. (NASD: JKHY) will replace EQT Corp. (NYSE: EQT) in t...
Source: PR Newswire
Date: November, 07 2018 17:57
Tech and consumer goods stock down in premarket trade
The TJX Companies (NYSE: TJX ) -49% . More news on: TJX Companies Inc., MiMedx Group Inc., Infinera Corporation, Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 07 2018 09:22
MiMedx institutes poison pill to thwart potential takeover; shares down 33% premarket
The board of MiMedx Group (NASDAQ: MDXG ) has unanimously authorized a limited duration shareholder rights plan that will go into effect at the open tomorrow, November 8, when its common shares will cease trading on Nasdaq. More news on: MiMedx Group Inc., Healthcare stocks news, Stocks ...
Source: SeekingAlpha
Date: November, 07 2018 08:23
MiMedx down 23% premarket on delisting notice
MiMedx Group (NASDAQ: MDXG ) slumps  23%  premarket in response to its announcement that Nasdaq will suspend trading in its common stock effective at the open tomorrow, November 8. More news on: MiMedx Group Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: November, 07 2018 08:14
MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq
MARIETTA, Ga. , Nov. 7, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that its Board of Directors has unanimously authorized the adoption of a limited duration shareholder rights plan (th...
Source: PR Newswire
Date: November, 07 2018 08:02
MiMedx Receives Nasdaq Delisting Notification
MARIETTA, Ga. , Nov. 7, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of th...
Source: PR Newswire
Date: November, 07 2018 08:00
MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference
MARIETTA, Ga. , Nov. 6, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that five poster abstracts reporting on the Company's EpiFix® dehydrated Human Amnion/Chorion Membrane (dHA...
Source: PR Newswire
Date: November, 06 2018 12:29
Healthcare And Biotechnology Dashboard - Update
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology is undervalued regarding historical averages, but profitability measu...
Source: SeekingAlpha
Date: November, 06 2018 11:32
MiMedx to Present Clinical and Scientific Studies at SAWC Fall Meeting
MARIETTA, Ga. , Oct. 31, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that five poster abstracts highlighting studies on the Company's EpiFix® dehydrated Human Amnion/Chor...
Source: PR Newswire
Date: October, 31 2018 13:26

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-145.154.945.1854.882,003,821
2018-01-2314.9114.9114.9914.561,601,304
2018-01-2214.1114.9014.9114.111,627,128
2018-01-1914.2414.2114.3314.061,312,659
2018-01-1814.1214.2714.4113.85938,744

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-074,116,8357,426,81255.4321Short
2018-11-06110,986196,22756.5600Short
2018-11-05160,314272,42458.8472Short
2018-11-02301,259544,48955.3288Short
2018-11-01426,364705,99360.3921Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MDXG.


About MiMedx Group, Inc. (NASDAQ: MDXG)

Logo for MiMedx Group, Inc. (NASDAQ: MDXG)

MiMedx Group, Inc. MiMedx Group is an integrated developer, manufacturer and marketer of patent protected biomaterial based products. The company is successfully emerging from a development focused start up phase into a fully integrated operating company with expertise to capitalize on its science and technology and its capacity to generate sales growth and profitability.

 

Contact Information

 

 

Current Management

  • Parker H. Petit / CEO
  • William C. Taylor / President, COO
  • Michael J. Senken / CFO
  • Leanna Moss / Director, Inv. Rel.
  • Parker H. Petit / Chairman
  • Bruce L. Hack /
  • William C. Taylor /

Current Share Structure

  • Market Cap: $812,775,270 - 05/17/2018
  • Issue and Outstanding: 111,034,873 - 10/13/2017

 


Recent Filings from (NASDAQ: MDXG)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 31 2018
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 26 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: July, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 02 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: June, 25 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 20 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: June, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 18 2018

 

 


Daily Technical Chart for (NASDAQ: MDXG)

Daily Technical Chart for (NASDAQ: MDXG)


Stay tuned for daily updates and more on (NASDAQ: MDXG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: MDXG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MDXG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MDXG and does not buy, sell, or trade any shares of MDXG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/